We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality.

When we think of type 2 diabetes, images of heart problems or kidney damage often come to mind. But lurking quietly behind these well-known complications is another serious threat—bone disease.

A pioneering study offers unprecedented insights into the bone immune microenvironment of type 2 diabetic mice, uncovering a ...

Paramagnetic rim lesions help confirm multiple sclerosis diagnoses and may have prognostic value. New evidence of an immune ...

Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at ...

Herpesvirus infection may contribute to Alzheimer’s disease through transposable element activation and neuroinflammation.

The Department of Justice (DOJ) issued a final rule (the "Rule") on December 27, 2024, implementing Executive Order 14117 "Preventing Access ...